Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2021-08-19
DOI
10.1080/17425255.2021.1970745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Treatment-related Cardiovascular Disease: Current Status and Future Research Priorities
- (2021) Miki Nonaka et al. BIOCHEMICAL PHARMACOLOGY
- Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis
- (2021) Lin Wang et al. JNCI-Journal of the National Cancer Institute
- Treatment and trials in non-metastatic castration-resistant prostate cancer
- (2021) Soum D. Lokeshwar et al. Nature Reviews Urology
- Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
- (2021) Panagiota Papazoglou et al. Frontiers in Cardiovascular Medicine
- Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies
- (2021) Cho-Won Kim et al. LIFE SCIENCES
- Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2020) Cora N. Sternberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer
- (2020) Veronica Mollica et al. Future Oncology
- Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
- (2020) Francesco Massari et al. Expert Opinion On Drug Safety
- Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
- (2020) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction
- (2019) John Esther et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs
- (2019) Andreas M. Beyer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
- (2019) E J Small et al. ANNALS OF ONCOLOGY
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
- (2018) Thomas Van den Broeck et al. EUROPEAN UROLOGY
- Cardiovascular toxicities of systemic treatments of prostate cancer
- (2017) Antonello Veccia et al. Nature Reviews Urology
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
- (2015) Matteo Santoni et al. Targeted Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started